You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Wegovy
since
auto-detected in 213 stories
4 days ago
Researchers analysed more than 400,000 social media posts in a bid to identify lesser-known issues linked to widely used GLP-1 medications semaglutide and tirzepatide.
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India ○
found
a story from CNBC ⚠️ › World News
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
12 days ago
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison ○
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
US approves new oral weight-loss pill developed by Eli Lilly ⊕
found
a story from The Guardian ⚠️ › International
Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy
The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral we…
13 days ago
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market ⊕
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator ⊕
The new recommendation will significantly expand access to Wegovy on the England's NHS.
NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes ⊖⊖
People who are not obese but overweight and at risk of serious cardiovascular events eligible for weekly jabs
The NHS in England is to offer more than 1 million people weight-loss drugs to reduce thei…
14 days ago
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly ⊕
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
21 days ago
Fat jabs for £10 a MONTH? Indian drug companies launch cheaper GLP-1s to rival Wegovy and Ozempic ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
Novo Nordisk's exclusive hold on semaglutide - the active ingredient in popular fat-busting GLP-1 jabs such as Wegovy and Ozempic - expired last Friday.
22 days ago
1 in 10 patients taking Wegovy and Ozempic lose less than 5 per cent of body weight despite high expectations ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
An estimated one in 50 UK adults now use fat jabs with demand soaring since 2023 when the National Institute for Health and Care Excellence (Nice) approved Wegovy for weight loss on the NHS.